{"mainPropery":{"diseaseId":10183,"diseaseName":"Hemoglobin Zurich","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10183/hemoglobin-zurich","synonyms":["Hb-Zurich"],"synonyms-with-source":[{"name":"Hb-Zurich"}],"identifiers":[]},"diseaseCategories":[],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=(hemoglobin%5BTitle%5D+AND+zurich%5BTitle%5D)+AND+hasabstract%5Btext%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Hemoglobin Zurich. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":350,"resourceId":1167,"resourceName":"Baby's First Test","descriptionText":"<a href='https://www.babysfirsttest.org/newborn-screening/conditions/hemoglobinopathies' target='_blank'>Baby's First Test</a> is the nation's newborn screening education center for families and providers. This site provides information and resources about screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"}],"overviewQuestion":{"questionId":7394,"questionText":"What is hemoglobin Zurich?","answerText":"<strong>Hemoglobin (Hb) Zurich</strong> is an inherited blood disorder. People with Hb Zurich have an abnormal form of Hb, a red blood cell (RBC) protein that binds to oxygen in the lungs. This abnormal Hb more readily binds to carbon monoxide (producing carboxyhemoglobin or COHb).[7289] Normally the level of COHb is less than 1-2% in adults. People with Hb Zurich tend to have COHb levels above 3%.[7287] The health effects of Hb Zurich tend to be mild compared to other inherited blood cell disorders.[7288] Symptoms usually develop only when the body is stressed due to an infection or fever or when exposed to certain drugs. Symptoms develop as a result of the premature breakdown of RBC (<a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/ha/\">hemolytic anemia</a>).&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19510.htm\">Click here</a> to visit MedlinePlus.gov and view an illustration of hemoglobin.<br />","dateModified":"2014-03-20T14:33:00"},"basicQuestions":[{"questionId":7395,"questionText":"What are the signs and symptoms of hemoglobin Zurich?","answerText":"People with Hemoglobin (Hb) Zurich do not tend to develop symptoms\r\nunless their red blood cells are exposed to certain chemicals,\r\ninfections, or to stress.[7287] People with hemoglobin Zurich should avoid <a href=\"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82269c80-5ca5-11dc-95bc-0002a5d5c51b\">sulfanilamide</a>.[7289] Some cases of Hb Zurich behave similarly to <a href=\"http://ghr.nlm.nih.gov/condition/glucose-6-phosphate-dehydrogenase-deficiency\">glucose-6-phosphate dehydrogenase</a>\r\n(G6PD) - in that they are especially sensitive to the oxidation of red\r\nblood cells.[7287] These individuals may benefit from avoiding or limiting\r\nexposure to G6PD triggers, such as antimalarial drugs, aspirin,\r\nnitrofurantoin,<span> n</span>onsteroidal anti-inflammatory drugs (NSAIDs), Quinidine, Quinine, Sulfonamide, fava beans, and mothballs. <br />\r\n<br />\r\n<a href=\"http://www.g6pd.org/\" target=\"_blank\">The G6PD Deficiency Association</a>,\r\nwhich is an advocacy group that provides information and supportive\r\nresources to individuals and families affected&nbsp;by G6PD deficiency,\r\nprovides a <a href=\"http://www.g6pd.org/en/G6PDDeficiency/SafeUnsafe.aspx\" target=\"_blank\">list of drugs and food ingredients</a> that can trigger hemolytic anemia.","dateModified":"2014-03-20T14:48:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1799,"authors":"Dugdale DC, Mason JR","articleTitle":"Glucose-6-phosphate dehydrogenase deficiency ","bookWebsiteJournalTitle":"MedlinePlus","date":"March 2010","url":"http://www.nlm.nih.gov/medlineplus/ency/article/000528.htm","dateAccessed":"2011-10-11T00:00:00"},{"referenceId":7287,"authors":"Steinberg MH, Orget BG, Higgs DR, Veatherall DJ","articleTitle":"Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management","bookWebsiteJournalTitle":"","date":"August 2009","volume":"","pages":"","url":"","dateAccessed":"2014-03-20T00:00:00","authors2":"","placeOfPublication":"Oxford","publisher":"Cambridge University"},{"referenceId":7288,"authors":"Benz EJ Jr, Ebert BL","articleTitle":"Hemoglobin Variants Associated With Hemolytic Anemia, Altered Oxygen Affinity, and Methemoglobinemias","bookWebsiteJournalTitle":"Hematology: Basic Principles and Practice, 6th ed","date":"2012","volume":"","pages":"","url":"","dateAccessed":"2014-03-20T00:00:00","authors2":"Hoffman","placeOfPublication":"","publisher":""},{"referenceId":7289,"authors":"Steinberg MH","articleTitle":"Unstable hemoglobin variants","bookWebsiteJournalTitle":"UpToDate","date":"2014","volume":"","pages":"","url":"","dateAccessed":"2014-03-20T00:00:00","authors2":"Basow M","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":7396,"questionText":"How might hemoglobin Zurich be treated?","answerText":"The most important aspect of management for hemoglobin (Hb) Zurich is to avoid\r\nagents that might trigger hemolytic anemia. Mild hemolytic anemia may not need treatment, as long as the\r\ncondition doesn't worsen. Treatments for severe hemolytic anemia include blood transfusions, medicines, and plasmapheresis. <a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/ha/treatment.html\">Click here</a> to visit the National Heart Lung and Blood Institute to learn more about treatment.","dateModified":"2014-03-20T14:48:00","resourceClassificationName":"Treatment","references":[{"referenceId":7290,"authors":"","articleTitle":"What is Hemolytic Anemia?","bookWebsiteJournalTitle":"National Heart Lung and Blood Institute","date":"April 2011","volume":"","pages":"","url":"http://www.nhlbi.nih.gov/health/health-topics/topics/ha/","dateAccessed":"2014-03-20T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":44423,"abbreviatedInquiry":"What is hemoglobin Zurich? I want to learn about the symptoms, suggested diet/nutrition, medicine's to stay away from, and lifestyle changes for someone diagnosed with this disorder. \r\nAny information you have. Many members of my family have this disorder and most have not had any info provided to them.","caseQuestions":[{"questionId":7394,"questionText":"What is hemoglobin Zurich?","answerText":"<strong>Hemoglobin (Hb) Zurich</strong> is an inherited blood disorder. People with Hb Zurich have an abnormal form of Hb, a red blood cell (RBC) protein that binds to oxygen in the lungs. This abnormal Hb more readily binds to carbon monoxide (producing carboxyhemoglobin or COHb).[7289] Normally the level of COHb is less than 1-2% in adults. People with Hb Zurich tend to have COHb levels above 3%.[7287] The health effects of Hb Zurich tend to be mild compared to other inherited blood cell disorders.[7288] Symptoms usually develop only when the body is stressed due to an infection or fever or when exposed to certain drugs. Symptoms develop as a result of the premature breakdown of RBC (<a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/ha/\">hemolytic anemia</a>).&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19510.htm\">Click here</a> to visit MedlinePlus.gov and view an illustration of hemoglobin.<br />","dateModified":"2014-03-20T14:33:00","references":[{"referenceId":7287,"authors":"Steinberg MH, Orget BG, Higgs DR, Veatherall DJ","articleTitle":"Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management","bookWebsiteJournalTitle":"","date":"August 2009","volume":"","pages":"","url":"","dateAccessed":"2014-03-20T00:00:00","authors2":"","placeOfPublication":"Oxford","publisher":"Cambridge University"},{"referenceId":7288,"authors":"Benz EJ Jr, Ebert BL","articleTitle":"Hemoglobin Variants Associated With Hemolytic Anemia, Altered Oxygen Affinity, and Methemoglobinemias","bookWebsiteJournalTitle":"Hematology: Basic Principles and Practice, 6th ed","date":"2012","volume":"","pages":"","url":"","dateAccessed":"2014-03-20T00:00:00","authors2":"Hoffman","placeOfPublication":"","publisher":""},{"referenceId":7289,"authors":"Steinberg MH","articleTitle":"Unstable hemoglobin variants","bookWebsiteJournalTitle":"UpToDate","date":"2014","volume":"","pages":"","url":"","dateAccessed":"2014-03-20T00:00:00","authors2":"Basow M","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":7395,"questionText":"What are the signs and symptoms of hemoglobin Zurich?","answerText":"People with Hemoglobin (Hb) Zurich do not tend to develop symptoms\r\nunless their red blood cells are exposed to certain chemicals,\r\ninfections, or to stress.[7287] People with hemoglobin Zurich should avoid <a href=\"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=82269c80-5ca5-11dc-95bc-0002a5d5c51b\">sulfanilamide</a>.[7289] Some cases of Hb Zurich behave similarly to <a href=\"http://ghr.nlm.nih.gov/condition/glucose-6-phosphate-dehydrogenase-deficiency\">glucose-6-phosphate dehydrogenase</a>\r\n(G6PD) - in that they are especially sensitive to the oxidation of red\r\nblood cells.[7287] These individuals may benefit from avoiding or limiting\r\nexposure to G6PD triggers, such as antimalarial drugs, aspirin,\r\nnitrofurantoin,<span> n</span>onsteroidal anti-inflammatory drugs (NSAIDs), Quinidine, Quinine, Sulfonamide, fava beans, and mothballs. <br />\r\n<br />\r\n<a href=\"http://www.g6pd.org/\" target=\"_blank\">The G6PD Deficiency Association</a>,\r\nwhich is an advocacy group that provides information and supportive\r\nresources to individuals and families affected&nbsp;by G6PD deficiency,\r\nprovides a <a href=\"http://www.g6pd.org/en/G6PDDeficiency/SafeUnsafe.aspx\" target=\"_blank\">list of drugs and food ingredients</a> that can trigger hemolytic anemia.","dateModified":"2014-03-20T14:48:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1799,"authors":"Dugdale DC, Mason JR","articleTitle":"Glucose-6-phosphate dehydrogenase deficiency ","bookWebsiteJournalTitle":"MedlinePlus","date":"March 2010","url":"http://www.nlm.nih.gov/medlineplus/ency/article/000528.htm","dateAccessed":"2011-10-11T00:00:00"},{"referenceId":7287,"authors":"Steinberg MH, Orget BG, Higgs DR, Veatherall DJ","articleTitle":"Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management","bookWebsiteJournalTitle":"","date":"August 2009","volume":"","pages":"","url":"","dateAccessed":"2014-03-20T00:00:00","authors2":"","placeOfPublication":"Oxford","publisher":"Cambridge University"},{"referenceId":7288,"authors":"Benz EJ Jr, Ebert BL","articleTitle":"Hemoglobin Variants Associated With Hemolytic Anemia, Altered Oxygen Affinity, and Methemoglobinemias","bookWebsiteJournalTitle":"Hematology: Basic Principles and Practice, 6th ed","date":"2012","volume":"","pages":"","url":"","dateAccessed":"2014-03-20T00:00:00","authors2":"Hoffman","placeOfPublication":"","publisher":""},{"referenceId":7289,"authors":"Steinberg MH","articleTitle":"Unstable hemoglobin variants","bookWebsiteJournalTitle":"UpToDate","date":"2014","volume":"","pages":"","url":"","dateAccessed":"2014-03-20T00:00:00","authors2":"Basow M","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":7396,"questionText":"How might hemoglobin Zurich be treated?","answerText":"The most important aspect of management for hemoglobin (Hb) Zurich is to avoid\r\nagents that might trigger hemolytic anemia. Mild hemolytic anemia may not need treatment, as long as the\r\ncondition doesn't worsen. Treatments for severe hemolytic anemia include blood transfusions, medicines, and plasmapheresis. <a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/ha/treatment.html\">Click here</a> to visit the National Heart Lung and Blood Institute to learn more about treatment.","dateModified":"2014-03-20T14:48:00","resourceClassificationName":"Treatment","references":[{"referenceId":7290,"authors":"","articleTitle":"What is Hemolytic Anemia?","bookWebsiteJournalTitle":"National Heart Lung and Blood Institute","date":"April 2011","volume":"","pages":"","url":"http://www.nhlbi.nih.gov/health/health-topics/topics/ha/","dateAccessed":"2014-03-20T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Hemoglobin_Zurich"}